RMJ. 2019; 44(4): 713-716
Is Antimullerian hormone a true ovarian marker for fibroid, Polycystic Ovary Syndrome and hypogonadotropic hypogonadism in infertile women?Benish Farooq, Sarwat jahan, Jehan Ara, Usman Ghani, Misbah Haneef, Ahsan Malik, Saleem Abbasi.
Objective: To measure Anti mullerian Hormone (AMH) concentration as a true ovarian marker in polycystic ovary syndrome (PCOS), fibroids and hypogonadotropic hypogonadism (HH).
Methodology: This study was a prospective comparative trial conducted from January to November 2014 at Department of Animal science, Quaid –e –Azam University in collaboration with Salma & Kafeel Medical Center, Islamabad, Pakistan. A total of 128 females were enrolled in the study.
Results: Significant increase (P
Infertility, AMH, PCOS, hypogonadotropic Hypogonadism, fibroids.